23-24 April 2024
Coventry Building Society Arena
37 mg – The Thin Red Line Between Health and Harm in Medication Dosing
Time: 10:45 am - 11:05 am
Date: 24 April 2024
24-april-2024 10:45
24-april-2024 11:05
Europe/London
37 mg – The Thin Red Line Between Health and Harm in Medication Dosing
In 2023 the majority of available medication is still mass production and shelf medication. While gender science, weight and bioavailability differences, special needs in pediatric medication or psycho-actives in particular shows us, that a one-fits-all medication has overcome long since, pharmaceutical industry has still not turned direction. Personalized dosed medication is the future of health… Read more »
Making PharmaceuticalsSynopsis
In 2023 the majority of available medication is still mass production and shelf medication. While gender science, weight and bioavailability differences, special needs in pediatric medication or psycho-actives in particular shows us, that a one-fits-all medication has overcome long since, pharmaceutical industry has still not turned direction.
Personalized dosed medication is the future of health treatment and a requirement of our time to improve side effects, reduce waste of pharmaceuticals and fight medication shortages.
Speakers
Ingo Krause Managing Partner - PrivMed® X AB
« Back